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Article

Pathogenic CD4+ T cells recognizing
an unstable peptide of insulin
are directly recruited into islets
bypassing local lymph nodes
James F. Mohan,1 Boris Calderon,1 Mark S. Anderson,2
and Emil R. Unanue1
1Department

of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
Center, University of California at San Francisco, San Francisco, CA 94115

In the nonobese diabetic mouse, a predominant component of the autoreactive CD4+ T cell
repertoire is directed against the B:9-23 segment of the insulin B chain. Previous studies
established that the majority of insulin-reactive T cells specifically recognize a weak peptideMHC binding register within the B:9-23 segment, that to the 12–20 register. These T cells
are uniquely stimulated when the B:9-23 peptide, but not the insulin protein, is offered to
antigen presenting cells (APCs). Here, we report on a T cell receptor (TCR) transgenic mouse
(8F10) that offers important new insights into the biology of these unconventional T cells.
Many of the 8F10 CD4+ T cells escaped negative selection and were highly pathogenic. The
T cells were directly recruited into islets of Langerhans, where they established contact with
resident intra-islet APCs. Immunogenic insulin had to be presented in order for the T cells to
localize and cause disease. These T cells bypassed an initial priming stage in the pancreatic
lymph node thought to precede islet T cell entry. 8F10 T cells induced the production of
antiinsulin antibodies and islets contained immunoglobulin (IgG) deposited on  cells and
along the vessel walls.
CORRESPONDENCE
Emil R. Unanue:
unanue@wustl.edu
Abbreviations used: ILN, inguinal LN; LTR, lymphotoxin 
receptor; NOD, nonobese diabetic; PLN, pancreatic LN;
T reg cell, regulatory T cell.

The development of autoimmune diabetes in
both humans and nonobese diabetic (NOD)
mice is highly influenced by specific alleles of
the class II MHC genes: HLA-DQ2 and HLADQ8 in humans and I-Ag7 in mice (Acha-Orbea
and McDevitt, 1987; Cucca et al., 2001). CD4+
T cells are essential in initiating the autoimmune response and, consequently, much emphasis has been placed on deciphering the relevant
self-peptides recognized by these cells driving
the development of diabetes (Anderson and
Bluestone, 2005).
The work of many laboratories has emphasized the importance of insulin as a critical target of the immune response for the development
of autoimmune diabetes (Zhang et al., 2008).
Extensive analysis of the T cell response directed
against insulin has highlighted an immunodominant segment of the insulin B chain, the B:9-23
(SHLVEALYLVCGERG) peptide (Wegmann
et al., 1994a,1994b; Daniel et al., 1995; Abiru
J.F. Mohan and B. Calderon contributed equally to this
paper.
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et al., 2001; Halbout et al., 2002). CD4+ T cells
recognizing B:9-23 are detected within the infiltrated islets of prediabetic mice and antigenic
masking of this epitope via mutation or tolerogenic expression in APCs diminished islet autoimmunity, signifying the essential role recognition
of the B:9-23 epitope in the development of diabetes (French et al., 1997; Jaeckel et al., 2004;
Nakayama et al., 2005). These studies and others
convincingly show that insulin is among the foremost targets in NOD diabetes, and its recognition by CD4+ T cells likely initiates a cascade of
downstream events driving both the amplification and diversification of the autoimmune
response, ultimately resulting in the complete
destruction of  cells (Nakayama et al., 2007;
Krishnamurthy et al., 2008). As a result, much
importance has been placed on understanding
© 2013 Mohan et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.rupress.org/terms). After six months
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/
licenses/by-nc-sa/3.0/).
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RESULTS
Generation of the 8F10 TCR transgenic mouse strain
The 8F10 TCR transgenic mouse was generated using the
rearranged TCR  chain (V13.3, TRAV5D-4/TRAJ53)
and  chain (V8.2, TRBV13-2/TRBD2/TRBJ2-7) cloned
from the 8F10 B:9-23 reactive type B T cell. In prior studies,
the 8F10 T cell exhibited strong reactivity for APC pulsed
with the B:9-23 peptide, while remaining completely unreactive to APC pulsed with the insulin protein. These T cells
specifically recognized the type B register 12–20, but completely lacked a response to the type A register 13–21 (Mohan
et al., 2010, 2011).
A single founder was obtained with genotypic and phenotypic characteristics indicative of a co-integration of both
the TCR  and  chains into a single genetic locus. The total
numbers of cells found in the thymus or spleen of 8F10 mice
were similar to those found in NOD mice. Flow cytometric
analysis of thymus and spleens showed normal T cell development in 8F10 mice (Fig. 1 A). The detection of T cells in
the periphery of 8F10 mice implicated their escape from negative selection in the thymus. The ratio of CD4+ versus CD8+
T cells was increased in both the thymus and to a lesser extent
in the spleen of 8F10 mice compared with NOD. As expected,
the development of CD8+ T cells was impaired in 8F10 mice,
seen by their reduced number in thymus and spleen, asserting
the notion that the TCR of 8F10 primarily interacts with the
MHC class II allele I-Ag7.
The vast majority (>95%) of CD4+ cells in 8F10 mice
stained positive with the TCR V8.1/8.2 antibody compared
with 20–25% of T cells in littermate controls (Fig. 1 B).
Expression of other TCR V alleles on 8F10 T cells was not
observed, thereby confirming allelic exclusion of the endogenous TCR  locus.
Currently, there is no available antibody that recognizes
the TCR V13.3 allele, so we could not assess the level of
surface expression for the transgenic TCR V chain. However, despite strong allelic exclusion of the endogenous TCR
V locus, many of the peripheral T cells in 8F10 mice exhibited successful rearrangements of endogenous TCR  chains.
Staining with an antibody that recognizes the TCR V2 allele
showed that a subset of 8F10 CD4+ T cells expressed this
particular TCR  chain (Fig. 1 B). Other minor populations
of 8F10 T cells expressed TCR V3.2, TCR V3.2, or TCR
V8.3, pointing to a significant fraction of transgenic T cells
expressing additional endogenous TCR  chains.This feature
is not unique to the 8F10 strain, as other TCR transgenics
expressed functional rearrangements of endogenous TCR 
gene products (Zal et al., 1994; Fousteri et al., 2012; Mingueneau
et al., 2012).The majority of the splenic CD4+ T cells in 8F10
mice exhibited a naive phenotype, proven by the predominance of CD62Lhi CD44low T cells (Fig. 1 C).
To restrict the TCR repertoire, 8F10 mice were crossed
onto the recombinase activating gene 1 (rag1)–deficient background. Crossing 8F10 mice onto the rag1-deficient background prevented the rearrangement of endogenous TCR
 chains, thus ensuring that only the transgenic TCR/
Diabetogenic insulin-reactive TCR transgenic mice | Mohan et al.
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the precise details involved in the recognition of the B:9-23
peptide by the immune system, particularly its binding interactions with I-Ag7 and the nature of the self-reactive T cells that
recognize this peptide MHC complex (Abiru et al., 2000; Yu
et al., 2000; Levisetti et al., 2007; Crawford et al., 2011; Mohan
et al., 2011).
Recently, we described a unique set of diabetogenic insulin-reactive CD4+ T cells that constitute the major component
of the T cell repertoire recognizing the B:9-23 peptide (Mohan
et al., 2010, 2011; Mohan and Unanue, 2012). Unlike conventional T cells, these T cells specifically recognized exogenous
insulin peptides offered to the APCs, but were incapable of recognizing the same peptide generated from processing of the insulin protein by the APC.The conventional T cells, referred to as
type A, represented a very small minority (<1%) of the T cells
recognizing the B:9-23 peptide. The unconventional T cells,
referred to as type B, were abundant (>99% of the T cells recognizing this peptide) in the periphery of NOD mice, indicating
that they might be impervious to negative selection in the thymus during development.A single amino acid shift of the B:9-23
peptide segment bound within the groove of I-Ag7 decisively
explained the discordant reactivities between type A and B
T cells (Mohan et al., 2011). Type A T cells recognized the
13–21 segment (SHLEALYVLVCGERG [sequence in bold,
the critical P9 residue in bold and italic]) of the B:9-23 peptide
bound to I-Ag7. In contrast, type B T cells recognized the 12–20
segment of the peptide (SHLVEALYLVCGERG [sequence
in bold, the critical P9 residue in bold and italic]) bound to
I-Ag7.The 13–21 register (type A) interacts more favorably with
I-Ag7, whereas the 12–20 register (type B) is largely unstable
and rapidly dissociates from I-Ag7. Importantly, free peptides
from insulin catabolism were identified in  cell secretory
granules and in the islet APCs, explaining the presentation of
the 12–20 register to the type B T cells (Mohan et al., 2010). It
is therefore highly plausible that the binding features and lack
of presentation of the 12–20 register after processing of insulin
protein explain why type B T cells are capable of escaping thymic selection.
Understanding the biology of these type B T cells that
recognize the weak binding register of the B:9-23 peptide,
only presented by APC from preformed peptides, requires a
TCR transgenic mouse. Here, we report on the generation
of a type B TCR transgenic (8F10) mouse specific for the
12–20 segment of the insulin B chain and show that these T cells
escape negative selection in the thymus, are spontaneously
recruited to the islets by intra-islet APCs charged with insulin peptide–MHC complexes, induce local inflammation,
and are highly pathogenic in the absence of other T cell specificities. The initial activation of these diabetogenic T cells does
not appear to occur in the pancreatic LNs (PLNs); instead,
they are directly recruited into islets from the vascular network through interactions with resident intra-islet APCs.Their
biological properties appear unique and quite different from
other insulin T cells described, specifically those with type A
reactivity (Du et al., 2006; Jasinski et al., 2006; Fousteri
et al., 2012).
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chains were expressed. Although the majority of thymocytes in 8F10 rag1/ mice were found in the immature
CD4/CD8 double positive population, a small proportion
of these cells matured into CD4+ single-positive T cells
(Fig. 1 D). Despite the low level of thymic selection in
8F10 rag1/ mice, T cells were present in the periphery
and were exclusively CD4+, representing roughly 5–10%
of the total splenocytes (Fig. 1 D and Discussion). 8F10
rag1/ mice contained a similar number of thymocytes
compared with 8F10 mice, but the number of splenocytes
was reduced (Fig. 1 E).
A subset of CD4+ single-positive 8F10 thymocytes expressed the regulatory T cell (T reg) marker Foxp3. In the
spleen, a sizable proportion (10–15%) of CD4+ T cells
expressed Foxp3 (Fig. 1 F). Foxp3 expressing T cells were
extremely rare, if not entirely absent in both the thymus
and periphery of 8F10 rag1/ mice (Fig. 1 F). Thus, the development of T reg cells in 8F10 mice was dependent on
the expression of rearranged endogenous TCR  chains,
which was prevented when the mice were bred to a rag1deficient background.
JEM Vol. 210, No. 11

Response of 8F10 TCR transgenic T cells
to the B:9-23 peptide
CD4+ T cells from the spleen of 8F10 mice responded robustly
to the B:9-23 peptide but did not respond to APC pulsed with
the insulin protein, confirming the type B reactivity previously reported using the parental T cell line (Fig. 2 A). As the
B:9-23 peptide binds in multiple overlapping registers to the
I-Ag7 molecule, we next examined their register reactivity
using nested register peptides, each of which contained a single binding register present within the B:9-23 peptide (Mohan
et al., 2011). As expected, these T cells responded robustly
to the weaker MHC binding B:12-20 register, poorly to the
stronger MHC binding B:13-21 register and had no response
to the very weak MHC binding register B:14-22 reported
by others (Crawford et al., 2011) when presented by I-Ag7
(Fig. 2 B). T cells from 8F10 rag1/ mice behaved in a similar manner, responding robustly to the B:9-23 peptide and
the 12–20 register but poorly to insulin and the 13–21 register
(Fig. 2, C and D). T cells from 8F10 rag1/ mice also recognized a nested 12–21 peptide, containing the minimal sequence
of both registers in tandem recognized by both type A and B
2405
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Figure 1. Analysis of 8F10 mice. (A, left) CD4 and CD8 flow cytometric profiles of NOD and 8F10 thymocytes; (right) percentages of cells found
among individual 8F10 mice. (B) Cell surface staining of 8F10 and NOD CD4+ splenocytes with anti-TCR V8.1/8.2 (left) or anti-TCR V2 (right). (C) Cell
surface staining of 8F10 CD4+ splenocytes with anti-CD44 and -CD62L. (D) Thymic (top left) and splenic (bottom left) profiles, and percentages of T cells
among individual 8F10 rag1/ mice (right). (E) Absolute number of thymocytes and splenocytes from 8F10 and 8F10 rag1/ mice. (F, left) Foxp3 staining of CD4+ single-positive thymocytes and CD4+ splenocytes of 8F10 and 8F10 rag1/ mice; (right) percentages of Foxp3+ T cells from individual 8F10
and 8F10 rag1/ mice. (A–F) Representative flow cytometry plots and cumulative data from two or more independent experiments (error bars, SEM).
Statistical analysis: Mann-Whitney U test, (*, P < 0.05; **, P < 0.005).
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Figure 2. Reactivity of 8F10 CD4+ T cells. (A) Primary
proliferation of isolated 8F10 CD4+ T cells in response to
B:9-23 peptide and insulin protein presented by CD11c+
DCs. (B) Primary proliferation of isolated 8F10 CD4+ T cells in
response to nested register peptides (core peptides) containing a single register of the B:9-23 peptide presented by
CD11c+ DCs. (C) Primary proliferation of splenocytes isolated
from 8F10 rag1/ mice incubated with insulin or B:9-23
peptide. (D) Enzyme-linked immunospot (ELISPOT) assay of
IL-2 secretion by splenocytes isolated from 8F10 rag1/
mice pulsed with the B:9-23 peptide, insulin protein, or
nested register peptides (core peptides). (A–D) Data representative of two independent experiments (error bars, SEM).

T cell entrance into islets
Immunofluorescence microscopy of isolated islets showed
the presence of 8F10 T cells within the islets at 3 wk of age,
the first point examined. At 5–10 wk of age, 60% of the
islets contained anywhere from a single T cell to >50 per islet
(Fig. 3 A). Older mice exhibited even further infiltration,
with roughly 90% of islets containing T cells and an overall
greater mean T cell burden per islet (Fig. 3 B). A phenotypic
analysis of the intra-islet T cells is described in the next section. Induction of VCAM-1 in intra-islet vessels was also observed in the infiltrated islets of 8F10 mice (Fig. 3, A and B).
VCAM-1 is an adhesion molecule not expressed in resting
islets, but rapidly up-regulated upon entrance of diabetogenic
T cells (Calderon et al., 2011a). Many of the T cells found
inside the islets were in direct contact with the resident intraislet APCs (Fig. 3 C). We previously reported that the resident
intra-islet APCs were heavily charged with B:9-23 peptide–
MHC complexes and stimulated B:9-23 reactive T cell hybridomas ex vivo (Calderon et al., 2008; Mohan et al., 2010). These
findings are in line with the notion that the resident intra-islet
APCs provide the local stimulatory signal within the islets to
infiltrating T cells.
IgG deposition was detected in many islets in 8F10 mice,
suggesting the presence of islet autoantibodies (Fig. 3 D). IgG
was found on the surface of the majority of islet cells in a speckled pattern and, intriguingly, in discrete deposits along the islet
2406

blood vessel walls (Fig. 3 D). In experiments in which nonspecific IgG was injected into mice, we did not observed localization in islets. The sera of 8–12-wk-old 8F10 mice contained
antibodies to native insulin, which were completely blocked
by the addition of soluble insulin in the assay (Fig. 3 E). The
antisera did not react with denatured insulin, B:9-23 peptide,
or with Nit-1 insulinoma cell membranes (Levisetti et al., 2003).
Sera from NOD mice did not show detectable levels of antiinsulin antibodies in our assay at this time. These observations
suggest that antiinsulin antibodies are made inside islets and
form immune complexes with insulin. The number of B cells
inside the islets during the early 8–12-wk period at the time
that antibodies were found was about one per islet (in 155 islets
examined). B cells were found in only 10% of the islets of nondiabetic NOD mice at the 8–12-wk period; this limited number has made it difficult at this point to establish their reactivity
(Carrero et al., 2013). Further studies aimed at characterizing
their specificity are currently in progress.
To gain a better understanding of the importance of antigen specificity in the recruitment of T cells into the islets,
we transplanted bone marrow cells of 8F10 rag1/ mice into
lethally irradiated B16:A-dKO mice (B16A). These mice express a single insulin gene with a tyrosine-to-alanine mutation at the 16th residue of the B:9-23 peptide and do not
develop diabetes (Nakayama et al., 2005).This mutation completely abrogates the antigenicity of the B:9-23 peptide for
both type A and B CD4+ T cells (Abiru et al., 2000, Mohan
et al., 2010). 8F10 localized to islets of NOD mice, whereas
localization was minimal in B16A mice. Unmanipulated B16A
mice showed minimal localization into islets when compared
with regular NOD mice (Fig. 3 F). Furthermore, diabetes developed in irradiated NOD mice transplanted with bone marrow of 8F10 rag1/ but not in B16A mice that received
the same cells (Fig. 3 F). To note, but not shown in Fig. 3,
is that a different CD4+ T cell, the BDC 2.5, induced diabetes
when adoptively transferred into irradiated B16A mice: 6/6
were diabetic within 8 d after the transfer of 4 × 106 activated T cells.
Diabetogenic insulin-reactive TCR transgenic mice | Mohan et al.
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insulin-reactive T cells. The reactivity to the nested 12–21 peptide was similar to the response observed for the B:9-23 peptide, both of which were weaker than the response observed
for the nested 12–20 peptide (Fig. 2 D). When APCs are offered the B:9-23 and the nested 12–21 peptide they bind to
I-Ag7 in multiple independent registers, thus partially diminishing the response compared with the nested 12–20 peptide
that specifically binds in the sole register, recognized by the
8F10 TCR. As expected, in six different trials islet APCs
presented to 8F10 as shown previously for all insulin-reactive
T cells (Mohan et al., 2010).
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Therefore, the localization of 8F10 T cells in islets is antigen specific and requires the recognition of insulin peptides.
The mechanisms of 8F10 T cell entry are currently under investigation, but preliminary results indicate that the entry does
not appear to involve chemokines, as treatment with pertussis
toxin did not block their entrance. In conclusion, type B reactive 8F10 T cells specifically infiltrated islets, initiated local
reactivity, and induced conformational antiinsulin autoantibodies analogous to those often found in the serum of type 1
diabetics and human patients at high risk.
Pathogenicity of 8F10 T cells
The development of histopathological lesions in the islets of
8F10 mice is shown in Fig. 4 A. Lymphocytic infiltration was
evident at 3 wk of age and increased as the mice aged. By 12 wk
of age, extensive infiltration was observed in the majority of
islets (Fig. 4 A). Islet infiltration was heterogeneous, some islets
exhibited a complete elimination of  cells, and some exhibited mild intra-insulitis, while many others exhibited strong
periinsulitic lesions with unaffected  cells (Fig. 4 B). A subset
(20% of islets) showed no signs of lymphocytic infiltration by
JEM Vol. 210, No. 11

histological examination. The heterogeneous nature in islet
pathology may well be related to the variations in the number
of resident intra-islet APC, which can vary from a single APC
to >10 APCs per islet (Calderon et al, 2008, 2012).
8F10 mice did not develop diabetes even when followed
for >8 mo, despite the inflammation observed in the majority
of islets.The finding of inflammation in which the periinsulitic
lesion predominates rather than a more destructive insulitis was
indicative of a level of suppression controlling  cell destruction. In support of this notion, 23% (±5%) of the T cells isolated
from islets were Foxp3+ (Fig. 4 C). The majority of T cells in
the islets, 93.2% (±3%), expressed low levels of CD62L, indicating an activation status. In contrast, the LN T cells expressed
high levels of CD62L, indicating a clear difference between
those in LNs (naive status) and those inside islets (Fig. 4 C).
Strikingly, when the 8F10 mice were crossed onto a rag1deficient background to exclude both endogenous TCR 
chain rearrangements and the development of Foxp3 T reg cells,
all 8F10 rag1/ mice rapidly developed diabetes, with the majority of mice succumbing to disease at 4–7 wk of age (Fig. 4
D and 4E). The pathological finding was restricted to the islets,
2407
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Figure 3. Recruitment of 8F10 T cells to
islets and islet reactivity. Islet cytology
evaluation of 8F10 female mice at 8–10 (A) or
14–19 (B) wk of age. (A and B, left) Number of
T cells (CD4+ or V8.1/8.2+) per individual
islet; bars indicate the median number of
T cells per islet. (A and B, right) Percentage of
islets positive for CD4+ T cells, V8.1/8.2+
T cells, VCAM-1+ expression on vessels and
mouse IgG+ deposition from pooled islets
(n = 5 mice per group) and 100 islets screened
for each marker. (C) Representative immunofluorescence image of an islet from A showing T cells by V8.1/8.2+ staining. Insets show
T cell–APC contacts. (D) Representative islet
from A showing mouse IgG deposition on the
 cells (left). Inset shows IgG+ deposition on
 cell membrane. (right) IgG+ deposition
found along intra-islet vessels from A.
(E) Radiolabeled I-125 insulin response of
antiinsulin antibody or 8F10 mouse sera
(8–12 wk) in the presence or absence of competing insulin (INS). (F) Unmanipulated controls (NOD and B16A) and bone marrow
chimeric mice (8F10/B16A and 8F10/NOD)
indicating the number of CD4+ T cells and the
percentages of islets containing T cells; bars
indicate the median number of T cells per
islet. Indicated is diabetes incidence of irradiated B16A and NOD recipients reconstituted
with 8F10 rag1/ bone marrow. (A–F) All
data representative of two or more independent experiments (error bars, SEM). Bars,
50 µm. Statistical analysis Mann-Whitney
U test (ns, not significant; ****, P < 0.0001).
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and no pathology was found in the ovaries, adrenals, thyroid,
liver, or kidneys.Thus, there was a dramatic shift in the pathogenicity of these T cells in 8F10 rag1/ mice. Splenocytes
from diabetic 8F10 rag1/ mice were highly pathogenic when
transferred into adult NOD rag1/ recipients at low numbers of T cells (104 splenocytes contained 500 to 1,000 CD4+
T cells; Fig. 4 F). These findings with 8F10 are compatible
with earlier studies involving the BDC 2.5 TCR transgenic
mouse extensively studied by the Mathis-Benoist laboratory, which also exhibited a level of regulation and greatly
enhanced pathogenicity when bred to a rag1-deficient background (Gonzalez et al., 2001; Chen et al., 2005).
In conclusion, 8F10 T cells can initiate and potently cause
diabetes in the absence of any other T cell specificities and
T reg cells. It is important to note that the diabetes incidence
in these mice, whose T cells specifically recognize the weaker
of the two registers present in the B:9-23 peptide, is considerably more rapid and penetrant when compared with other reported B:9-23 TCR transgenic strains (Du et al., 2006; Jasinski
et al., 2006).
2408

8F10 T cells do not require PLNs
A longstanding tenet in autoimmunity is that LNs draining
the target tissue are important in the priming of autoreactive
lymphocytes. Strong evidence indicates that the initiation of diabetogenesis commences with the priming of islet reactive T cells
in the PLNs before their recruitment to the islets (Höglund
et al., 1999; Calderon and Unanue, 2012). Indeed, NOD mice
lacking the PLN did not develop diabetes and for the most
part were devoid of overt islet infiltration (Gagnerault et al.,
2002; Levisetti et al., 2004). Furthermore, findings of two diabetogenic TCR transgenic models, namely BDC 2.5 and 8.3NOD, representing islet CD4+ and CD8+ T cells, respectively,
showed their proliferation in the PLNs from an early age.The
results suggest that priming of diabetogenic T cells in the PLNs
precedes the migration of these T cells into the islets (Höglund
et al., 1999; Zhang et al., 2002). How exactly the PLN functions in T cell priming and its requirement in localization of
T cells to the islets are not entirely known.
Previously, we reported that insulin-reactive T cells recognized endogenous presentation of B:9-23 by resident intra-islet
Diabetogenic insulin-reactive TCR transgenic mice | Mohan et al.
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Figure 4. 8F10 T cells are specifically recruited
to the islets and are highly pathogenic. (A) Insulitis scoring of pancreatic sections from 8F10 mice
stained with hematoxylin and eosin (n = 4–7 mice
per age group). (B) Hematoxylin and eosin–stained
pancreatic section from a representative islet of a
6-wk-old 8F10 mouse showing the periinsulitic
lesion. (C) Flow cytometry analysis of islet-infiltrating
8F10 CD4+ T cells and T cells from other anatomical
locations (PLN, ILN [inguinal LN], and spleen) in
10-wk-old 8F10 mice. Dispersed islets were pooled
from 4 mice. (D) Pancreatic section from a diabetic
5-wk-old 8F10 rag1/ mouse showing an islet with
destructive insulitis. (E) Spontaneous diabetes incidence in 8F10 (n = 60) and 8F10 rag1/ mice
(n = 22). (F) Adoptive transfer of splenocytes from
8F10 rag1/ mice into NOD rag1/ recipient mice
(106, n = 10; 105, n = 8; 104, n = 4). (A–F) Cumulative
data pooled from at least two independent experiments (error bars, SEM).
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and results in mice devoid of LNs which remain absent for
their lifespan (Rennert et al., 1996, 1998; Mandik-Nayak
et al., 2002; Levisetti et al., 2004). 8F10 mice exposed to soluble LTR-Ig in utero (8F10 nodeless) had absent axillary, inguinal LN (ILN), and popliteal LNs, and of particular relevance
to this study, they also lacked the PLN. Importantly, 8F10 nodeless mice did not exhibit any discernible differences in the
splenic T cell repertoire compared with T cells that developed
in 8F10 mice.
Immunofluorescence of isolated islets from 8F10 nodeless
mice indicated that a large proportion of islets were infiltrated
with T cells by 5 wk of age (Fig. 6 A). The level of islet T cell
infiltration in 8F10 nodeless mice was on par with the amount
of infiltration observed in normal 8F10 mice (Fig. 6 B). Histological analysis showed mononuclear infiltrates in the islets
of 8F10 nodeless mice (Fig. 6 C). Furthermore, 8F10 rag1/
nodeless mice developed diabetes with similar kinetics to
8F10 rag1/ mice (Fig. 6, D and E). Hence, the PLN is dispensable for the recruitment of 8F10 T cells into the islets,
and the development of diabetes in 8F10 rag1/ mice does
not depend on an initial priming stage in the PLN.
DISCUSSION
In this study, we report on the unique biological features of an
important set of insulin-reactive CD4+ T cells, those that recognize the weak 12–20 register of the insulin B:9-23 segment.

Figure 5. 8F10 T cells are not effectively
primed in the PLN. CFSE dilution of 8F10
CD4+ T cells in the PLN of recipient NOD mice
of the indicated ages at days 3 (A) and 5 (B)
after transfer and analyzed by flow cytometry.
(C) CFSE dilution of purified transferred
CD4+ CD25 8F10 T cells in the PLNs of NOD
mice. (D) In vitro CFSE dilution of purified
8F10 CD4+ T cells in the presence of irradiated splenocytes pulsed with B:9-23 peptide.
(E) CFSE dilution of 8F10 CD4+ T cells transferred and isolated from the islets of
8-wk-old NOD mice. (F) CFSE dilution of BDC
2.5 CD4+ T cells in the PLN of 8-wk-old NOD
mice.(G) Pooled results from multiple experiments depicting percentage of divided 8F10
and BDC 2.5 CD4+ T cells in the ILN, PLN, and
islets of NOD recipients. Representative data
of at least two independent experiments (A–F)
or cumulative data of 2–6 independent experiments (G; error bars, SEM; ns, not significant; **, P < 0.005; ***, P < 0.0005).
JEM Vol. 210, No. 11
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APCs but not by APCs in the draining PLN (Mohan et al.,
2010). These results were unexpected but not entirely conclusive, as ex vivo T cell assays are far less sensitive than those
performed in vivo. In light of these issues and the finding of
8F10 T cells in islets from an early age, we tested the role of
the PLN in priming of insulin-reactive T cells in vivo. Adoptively transferred, CFSE-labeled 8F10 CD4+ T cells did not
proliferate in the PLN of recipient NOD mice that ranged in
age from 4 to 13 wk old (Fig. 5, A and B). The lack of proliferation observed with 8F10 T cells in the PLN or other nearby
LNs, did not appear to result from active suppression as 8F10
T cells also failed to proliferate in the absence of CD25+ cells
(Fig. 5 C). 8F10 T cells proliferated vigorously in vitro in the
presence of APC and antigen (Fig. 5 D). Finally, despite the
lack of reactivity in the PLN, 8F10 T cells were recruited to
the islets and proliferated locally, most likely triggered by the
resident intra-islet APC (Fig. 5 E). In agreement with others,
we found that the BDC2.5 TCR transgenic T cells proliferated in the PLN (Fig. 5 F).The results summarized in Fig. 5 G,
indicate that unlike other diabetogenic T cells, 8F10 T cells
are only stimulated directly within the islets and not in the
draining PLN.
To study the role of the PLN we generated 8F10 mice
that lacked most LNs by treating pregnant mice with a soluble lymphotoxin -receptor (LtR-Ig) decoy protein. This
treatment inhibits the development of most LNs in progeny
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Figure 6. Islet-infiltrating 8F10 T cells do not
require priming in the PLN. (A) Immunofluorescence of a representative islet from 5-wk-old 8F10
nodeless mice. Inserts show T cell–APC contacts.
(B) Quantitative analysis showing percentage of
infiltrating CD4+ T cells in islets of 5-wk-old 8F10
and 8F10 nodeless mice. (C) Hematoxylin and eosin–
stained pancreatic section from a 12-wk-old 8F10
nodeless mouse. (D) Hematoxylin and eosin–stained
pancreatic section from a 5-wk-old 8F10 rag1/
nodeless diabetic mouse. (E) Spontaneous diabetes
incidence of 8F10 (n = 10), 8F10 nodeless (8F10 NL,
n = 9), 8F10 rag1/ (8F10 rag1/, n = 4), and 8F10
rag1/ nodeless (8F10 Rag rag1/ NL, n = 6) mice.
Representative (A, C, and D) or cumulative (B and E)
data pooled from two to three independent experiments. Bars, 50 µm. Error bars, SEM.
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of the mature hormone from the prohormone is subjected to a
specific proteolytic program; and lastly, the biochemical features of the 12–20 register, namely, its poor binding to I-Ag7 reduces the chances for efficient presentation. In toto, it is likely
that the combination of these features result in the inability to
purge 8F10 T cells, despite their inherent pathogenicity.
Concerning the sites of presentation in peripheral sites,
either splenic and/or blood-borne APCs could potentially
take up and present insulin molecules circulating through the
bloodstream. Systemic presentation has not been observed,
likely because of the low concentration of insulin in blood
coupled with the weak interaction of B:9-23 with I-Ag7. The
third location, the PLN which drains the pancreas, represents an
important site, having been shown to prime diabetogenic T cells
and as necessary for the development of diabetes (Höglund
et al., 1999; Gagnerault et al., 2002; Turley et al., 2003;
Levisetti et al., 2004;). Surprisingly, insulin was presented
either very weakly or not at all in the PLNs. The biochemical
features of this peptide, namely the short lifespan of the register bound to I-Ag7, likely explains the lack of detectable presentation of B:9-23 in the PLN.
8F10 T cells were recruited to the islets from an early age,
indicating that either denatured insulin or free B chain peptides
Diabetogenic insulin-reactive TCR transgenic mice | Mohan et al.
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The 8F10 T cells: (a) evaded negative selection and peripheralized; (b) entered the islets of Langerhans, where they interacted with resident intra-islet APCs and were pathogenic;
(c) did not require priming in the PLN to cause diabetes; and
(d) served as helper cells inducing antiinsulin antibodies to
native insulin, despite their reactivity to only a preformed
peptide segment of the insulin molecule.
These mice provide new insights into the anatomical location where autoreactive T cells recognize insulin. There are four
potential anatomical sites for presentation of insulin: (a) centrally
by the thymic APC system; (b) by APC of various secondary
lymphoid organs; (c) specifically by APC in the PLN; and (d) by
resident APCs found in the islets of Langerhans. First, the thymus epithelium is known to express insulin under the control of
AIRE to purge the T cell repertoire of insulin-reactive cells
(Anderson et al., 2002). Thymic insulin expression likely accounts for the strong selection against type A B:9-23 reactive
T cells. Under normal conditions, however, T cells that recognize the unstable 12–20 register akin to 8F10 T cells, are not interacting or interacting poorly with insulin-expressing APC in
the thymus for several complementary reasons: expression of
insulin by epithelial cells is too low; processing of insulin in the
thymus is different from that in  cells in which the generation
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One issue to discuss concerns the lymphopenia observed
in the peripheral compartment of 8F10 rag1/ mice. This
result was somewhat unexpected because prior studies have
shown that B:9-23-reactive type B T cells did not appear to
be under selective pressure in thymus (Mohan et al., 2010,
2011). Generally, it has been assumed that lymphopenia observed in the periphery of TCR transgenics on rag1-deficient
backgrounds was indicative of negative selection against the
TCR of investigation. Although this explanation may be valid
in certain instances for TCR transgenic models, it should be
noted that this is not always the case. Contrary to this notion,
a recent study convincingly shows that a highly restricted monoclonal TCR expression profile in the thymus, particularly on
the NOD background, can result in insufficient positive selection, thus also augmenting the ability of TCR transgenic T cells
to mature and peripheralize (Mingueneau et al., 2012). Specifically, early expression of TCR transgenes leads to overseeding of the double-positive thymocyte compartment in NOD
mice, generating heightened competition for positive selection niches, and thereby reducing the likelihood that many of
these developing T cells will be effectively positively selected
by a limited pool of selecting ligands. In agreement with this
model, our study found ample rearrangement of endogenous
TCR chains in 8F10 mice and an abundant pool of doublepositive thymocytes in 8F10 rag1/ mice, suggesting similar
mechanisms may be involved. Whether insufficient positive
selection can explain the low number of CD4+ T cells observed
in 8F10 rag1/ mice will require further investigation, but it
represents a highly plausible explanation, especially when taken
in consideration with our previous studies showing a lack of
negative selection against type B B:9-23-reactive T cells in the
polyclonal repertoire of NOD mice (Mohan et al., 2010, 2011).
A final issue to note is that 8F10 rag1/ mice exhibited a
much more rapid and penetrant diabetic process compared
with two other B:9-23-reactive TCR transgenic strains on
rag1-deficient backgrounds. One insulin-reactive strain (2H6),
presumably with type A reactivity, did not exhibit islet pathology and was shown to have suppressive qualities (Du et al., 2006).
The second strain (BDC 12–4.1), created by the Eisenbarth
laboratory (Jasinski et al., 2006), was included in our earlier
studies of type A and B insulin-reactive T cells. CD4+ T cells
from these mice were conclusively shown to exhibit type A
reactivity, solely reacting with the stronger 13–21 binding register of the B:9-23 peptide (Mohan et al., 2011). Paradoxically, significantly fewer of the BDC 12–4.1 rag1/ mice
developed diabetes, and they contained a sizable population
of T reg cells compared with 8F10 rag1/ mice (Jasinski
et al., 2006; Fousteri et al., 2012). In toto, it suggests that strong
selective pressure is being exerted on type A 13–21 reactive
T cells, whereas considerably less selective pressure is exerted
on T cells recognizing the type B 12–20 register. We speculate that in the naturally arising polyclonal T cell repertoire of
NOD mice, selective pressure will eliminate the majority of
type A B:9-23 reactive T cells, but the limited number that
do escape selection have a much greater likelihood of developing regulatory or anergic phenotypes in the periphery. The
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were naturally and constitutively presented there. Indeed, we
previously reported on the finding of insulin peptides within
most of the resident intra-islet APCs, a finding compatible
with the present identification of 8F10 T cells establishing
intimate contacts with the resident intra-islet APCs. The abundant concentration of insulin in  cells combined with the
existence of preformed insulin peptides and the constant local
sampling and presentation by resident intra-islet APCs outweigh the poor biochemical properties of this register and
allows for efficient presentation (Mohan et al., 2010, 2011).
An important new finding concerns the requirement for recognition of immunogenic insulin in islets for localization of
8F10 T cells as exemplified in their absence in B16A mice. The
finding denotes immunological specificity for the localization
of the diabetogenic T cells. In previous studies, we indicated
that the localization of specific diabetogenic T cells did not
require chemokine responses (Calderon et al., 2011a). Intraislet APCs are closely associated with the islet vasculature and
extend dendrites through the fenestrated endothelium into the
lumen of the islet capillaries (Calderon et al., 2011b). Although
not conclusive, it is likely that these dendrites, protruding into
the local bloodstream and highly charged with B:9-23 peptide–MHC, can actively recruit insulin-reactive T cells directly
from the adjacent bloodstream into the islets.
An important new finding is that 8F10 T cells migrated
into the islets even though they had not been activated in the
PLN and caused diabetes. These findings place a qualification
on the role of the PLN. It raises important issues concerning
the interaction between insulin-reactive T cells, believed to be
among the earliest infiltrating immune cells, and other isletreactive CD4+ and CD8+ T cells in which the PLN is an integral site of activation. Our findings that very few T cells were
found in the islets of the B16A mice is another argument for
insulin T cells driving the initiation of diabetes. Moreover,
does the recruitment of insulin-reactive T cells directly into the
islets influence levels of islet antigen presentation in the PLN?
It is conceivable that inflammation induced by early infiltrating, insulin-specific T cells leads to an increase in islet-specific
antigen presentation in the PLN, providing both amplification
and diversification of the antiislet response necessary for diabetes development. In strong support of this statement are the
findings in which a robust CD8+ T cell response in the PLN
to a class I MHC epitope derived from the islet-specific glucose6-phosphate catalytic subunit depended on the prior development of the antiinsulin response (Krishnamurthy et al., 2006).
The emergence of antiinsulin antibodies and the localization in islets was a surprise. A prior study showed that the TCR
 chain from insulin-reactive T cells was sufficient to induce
circulating insulin autoantibodies (Kobayashi et al., 2008).
Our findings indicate that the 8F10 is acting as a helper T cell
for B cells that react with native insulin.These findings are intriguing in the perspective of where B cells interact with insulin, that is, whether with circulating insulin, or directly inside
the islets. Although we do not have evidence that the IgG in
islets or the intra-islet B cells are insulin-reactive, it is tempting to speculate that the islet is a site of B cell selection.
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type B–reactive T cells on the other hand, pass through thymic selection with relative ease and potentially represent the
majority of true pathogenic insulin-reactive T cells.
In conclusion, it is becoming more evident that insulinreactive type B T cells represent not only a particularly relevant autoreactive T cell population, but are also central players
in the response against B:9-23 during diabetogenesis. Understanding of the pathogenic and/or suppressive capabilities of
type A and B subsets independently during the disease process
will not only benefit the basic understanding of autoimmunity
in NOD mice, but may also aid in the future development of
antigen-specific therapies aimed at preventing type 1 diabetes.
MATERIALS AND METHODS

Generation of 8F10 TCR transgenic mice. To generate the transgenic mice,
the TCR  chain (V13.3, TRAV5D-4/TRAJ53) and  chain (V8.2,
TRBV13-2/TRBD2/TRBJ2-7) sequences were isolated by PCR from cDNA
sequences generated from the 8F10 T cell. The TCR  and  chains were
cloned into CD2 and CD4 expression vectors, respectively (Zhumabekov et al.,
1995; Wang et al., 2001). Linearized TCR  and  expression constructs were
co-injected into NOD embryos. Mice were genotyped by PCR with the following primer pairs; TCR  forward 5-GCAGTCTCCAAAGAATTCGC
CACC-3 and TCR  reverse 5-CAGTTTGTAATTGCTGCCTCCACT-3;
TCR  forward 5-ATGCACTGCTGCTATTGCTCAGGA-3 and TCR 
reverse 5-CCGCTGGCACAGAAGTACACTGAT-3.
Flow cytometry. Single-cell suspensions isolated from various organs were
stained with the following antibodies against CD8, TCR V 8.1/8.2, TCR
V 4, TCR V 2, and CD62L (BD); CD3e and Foxp3 (eBioscience); and
CD4, CD69, and CD44 (BioLegend). Stainings were performed according
to the manufacturer’s protocol. Flow cytometry samples were collected
using a FACSCalibur and FACSCanto II flow cytometers (BD) and analyzed
using Flow Jo software (Tree Star).
Islet isolation and handling for immunofluorescence. Islets were isolated
with some modifications of the original protocol (Lacy and Kostianovsky,
1967; Salvalaggio et al., 2002; Li et al., 2009). In brief, pancreata were isolated and treated with collagenase, followed by several steps of centrifugation
and washing, and finally, islets were picked by hand. Immunofluorescence
analysis was performed as previously described (Calderon et al., 2008). Isolated
islets maintained on ice were preincubated with 10% Fc block, followed by
staining with specific labeled monoclonal antibodies for: anti-CD11c Alexa
Fluor 488 (clone N418) and anti-CD4 PE (clone RM4-5; BioLegend); antiTCR V 8.1/8.2 PE (clone MR5-2; BD); anti-CD31 Alexa Fluor 647
(clone 2B8; provided by S. Bogen, Boston University School of Medicine,
Boston, MA); goat anti–mouse IgG (H+L) Alexa Fluor 488 (Life Technologies);
and biotinylated anti–VCAM-1 (clone 429; eBioscience). Streptavidin Alexa
Fluor 555 (Life Technologies) was used as the secondary reagent. Islets were
fixed in 1% paraformaldehyde before epi-illumination microscopic analysis.
Percentages of islets with infiltrating T cells, VCAM-1 expression, and IgG
deposition were generated by scoring 100 individual purified islets from a
pool of five mice per group.
In vitro T cell activation assays. Proliferation of primary 8F10 T cells was
performed in triplicate in 96-well round bottom tissue culture plates. 105
CD4+ T cells enriched from the splenocytes of 8F10 mice were incubated
2412

In vivo T cell activation assays. Activation of T cells in vivo was performed using a standard adoptive transfer system using CFSE-labeled splenocytes. In brief, splenocytes were dissociated into a single-cell suspension.
After RBC lysis, splenocytes were washed two times in PBS and incubated
with 1.6-µM CFDA SE (Life Technologies) per 107 cells for 10 min at 37°C.
Reaction was stopped by adding an equal volume of DMEM + 10% FCS.
In other assays CD4+ CD25 splenic primary T cells were isolated by magnetic cell separation (Miltenyi Biotec) before labeling. After CFSE labeling,
2–5 × 107 labeled splenocytes or 0.5–1 × 107 CD4+ CD25 purified T cells
were transferred i.v. into NOD recipients. Inguinal, PLNs, and/or islets were
harvested 72 or 120 h after transfer and dissociated into single-cell suspensions. Adoptively transferred CFSE cells were gated either on CD3e+ or CD4+
for 8F10 and BDC 2.5, and by TCR V8.1/8.2+ CFSE+ and TCR V 4+
CFSE+, respectively.
Antiinsulin antibody detection and diabetes monitoring. 125I-labeled
insulin was purchased from Perkin Elmer (Cat# NEX420010UC). 125I-insulin
(150,000 cpm) was added to tubes containing sera with or without 10 µg/ml
unlabeled insulin as competitor and incubated at 4°C for 72 h. After incubation, 25 µl of 25% Protein-A Sepharose was added and incubated on ice for
1–2 h, shaking periodically. The entire sample was layered over 200 µl of an
oil mixture [60% dibutylphthalate (Acros #16660-0010)/40% dioctylphthalate (Acros #11709-0010)] in micro test tubes (Bio-Rad Laboratories). Tubes
were spun for 4 min in a Beckman 152 microfuge. After spinning, tubes were
cut above the pelleted Sepharose, and both the Sepharose pellet and supernatant were counted in a gamma counter.
LtR-Ig treatment. Pregnant female breeders used to generate 8F10
and 8F10 rag1/ offspring were treated with soluble LtR-Ig using a
previously established protocol (Rennert et al., 1996). Timed pregnant
females were treated i.v. with 200 µg of soluble LtR-Ig fusion protein
on days 14 and 17 of gestation. Progeny used in this study were visually
inspected and determined to be devoid of ILNs, PLNs, popliteal LNs, and
axillary LNs.
Statistical analysis. Mann–Whitney U test was used to determine the level
of significant differences between samples and was plotted using GraphPad
Prism 5 (GraphPad Software, Inc.).
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Mice. NOD, NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/DoiJ (BDC
2.5), NOD.Cg-Tg(TcraTcrbNY8.3)1Pesa/DvsJ (8.3-NOD), NOD on
the rag1/, and NOD.Cg-Tg(Ins2*Y16A)1Ell Ins1tm1Jja Ins2tm1Jja/GseJ
(B16:A-dKO) were obtained from The Jackson Laboratory and maintained
in specific pathogen–free conditions. All animal studies were approved by
the animal study committee of Washington University.

with 105 CD11c+ DC isolated from NOD mice treated with Flt-3L at indicated doses of antigens. Flt-3L treatment was used to increase the yield of DC
present in treated mice. Both CD4+ T cells and CD11c+ DC were isolated
from spleens of donor mice using standard magnetic cell separation (Miltenyi
Biotec). In other assays with 8F10 rag1/ mice, unfractionated splenocytes at
a density of 5 × 105 cells per well were used. Proliferation was measured by
[3H]thymidine incorporation over the last 24 h of a 72-h culture. ELISPOT
assays were performed according to the manufacturer’s protocol: 8F10 rag1/
splenocytes were incubated overnight with antigen and analyzed for IL-2
secretion. Insulin was purchased from Sigma-Aldrich. All peptides used in this
study were synthesized in the laboratory using standard protocols and were
previously described. In brief, nested register peptides, based off the native
B:9-23 peptide SHLVEALYLVCGERG, were synthesized with identical
artificial flanking residues using the following sequences: 12–20 core, TEGVEALYLVCG-GGS; 12–21 core, EGVEALYLVCGE-GGS; 13–21 core,
TEG-EALYLVCGE-GGS; and 14–22 core; TEG-ALYLVCGER GGS.
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